BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18199958)

  • 1. Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma.
    Jacob A; Lee TX; Neff BA; Miller S; Welling B; Chang LS
    Otol Neurotol; 2008 Jan; 29(1):58-68. PubMed ID: 18199958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of phosphatidylinositol 3-kinase in gonadotropin-releasing hormone-induced gonadotropin alpha- and FSHbeta-subunit genes expression in clonal gonadotroph LbetaT2 cells.
    Mutiara S; Kanasaki H; Harada T; Oride A; Miyazaki K
    Mol Cell Endocrinol; 2008 Feb; 283(1-2):1-11. PubMed ID: 18206295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young environment reverses the declined activity of aged rat-derived endothelial progenitor cells: involvement of the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Zhu G; Song M; Wang H; Zhao G; Yu Z; Yin Y; Zhao X; Huang L
    Ann Vasc Surg; 2009; 23(4):519-34. PubMed ID: 19540437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG; Spurlock DM
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
    Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
    J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
    Lasak JM; Welling DB; Akhmametyeva EM; Salloum M; Chang LS
    Laryngoscope; 2002 Sep; 112(9):1555-61. PubMed ID: 12352662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AILIM/ICOS-mediated elongation of activated T cells is regulated by both the PI3-kinase/Akt and Rho family cascade.
    Nukada Y; Okamoto N; Konakahara S; Tezuka K; Ohashi K; Mizuno K; Tsuji T
    Int Immunol; 2006 Dec; 18(12):1815-24. PubMed ID: 17077177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphatidylinositol 3' kinase-Akt-mammalian target of rapamycin pathway in smooth muscle tumors of the uterus: selected protein expression patterns and their clinicopathologic implications.
    Fadare O; Renshaw I; Olson SJ; Liang SX
    Int J Gynecol Pathol; 2011 May; 30(3):244-51. PubMed ID: 21464729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Akt in cancer therapy.
    LoPiccolo J; Granville CA; Gills JJ; Dennis PA
    Anticancer Drugs; 2007 Sep; 18(8):861-74. PubMed ID: 17667591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors.
    Verheul HM; Salumbides B; Van Erp K; Hammers H; Qian DZ; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2008 Jun; 14(11):3589-97. PubMed ID: 18519793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the PI3-K/Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone.
    Wang L; Gang Zhang Z; Lan Zhang R; Chopp M
    J Cereb Blood Flow Metab; 2005 Sep; 25(9):1150-8. PubMed ID: 15815584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery.
    Lee DJ; Maseyesva B; Westra W; Long D; Niparko JK; Califano J
    Otol Neurotol; 2006 Feb; 27(2):213-9. PubMed ID: 16436992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF and bFGF promote invasion that is modulated by PI3/Akt kinase and Erk in vestibular schwannoma.
    Blair KJ; Kiang A; Wang-Rodriguez J; Yu MA; Doherty JK; Ongkeko WM
    Otol Neurotol; 2011 Feb; 32(2):308-14. PubMed ID: 21178801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of phosphatidylinositol 3-kinase in human breast carcinoma].
    Zhang Y; Song M; Mi XY; Wang H; Song JY
    Ai Zheng; 2002 May; 21(5):489-92. PubMed ID: 12452038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner.
    Huang J; Yang M; Liu H; Jin J
    Acta Pharmacol Sin; 2008 Aug; 29(8):951-64. PubMed ID: 18664328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of PI3-K/Akt pathways in nanoparticle realgar powders-induced apoptosis in U937 cells.
    Xi RG; Huang J; Li D; Wang XB; Wu LJ
    Acta Pharmacol Sin; 2008 Mar; 29(3):355-63. PubMed ID: 18298901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
    Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
    Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.